feed,title,long_url,short_url
Benzinga,Eledon Shares Climb After Securing FDA Nod For Mid-Stage Kidney Disease Study,https://benzinga.com/general/biotech/22/09/28765462/eledon-shares-climb-after-securing-fda-nod-for-mid-stage-kidney-disease-study,https://bit.ly/3THWv1r
Benzinga,After-Hours Alert: Why UiPath Stock Is Plunging,https://benzinga.com/news/earnings/22/09/28765340/after-hours-alert-why-uipath-stock-is-plunging,https://bit.ly/3Bisz4w
